Patients with haemoglobinopathies and chronic hepatitis c: a really difficult to treat population in 2016?

Conclusions: More than 1/3 of patients with haemoglobinopathies suffered from CHC. Response rates to antiviral treatment seem to be similar to other patients with CHC, while treatment with DAAs was very effective and safe even in difficult to treat patients (most null responders with severe fibrosis) suggesting that this group of HCV patients should no longer be regarded as a difficult to treat.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Source Type: research